Posted inEmerging Market
360 One Group CEO Karan Bhagat Acquires Novartis India Shares in Rs 22 Crore Deal
Karan Bhagat purchases 1.3 lakh shares of Novartis India for Rs 22 crore through an internal transfer from his firm Kyrush Investments.
Posted inEmerging Market
How Veteran Investor Vijay Kedia Achieved 100x Returns With Neuland Laboratories
Discover how prominent investor Vijay Kedia turned a small investment in Neuland Laboratories into nearly 100x returns through strategic foresight.
Posted inEmerging Market
Gland Pharma Shares Drop 3 Percent Following Major Block Deals
Gland Pharma stock declined by 3 percent after a massive block deal involving 1.2 crore shares, with Fosun Pharma expected to be the primary seller.
Posted inMarket
Trump’s Proposed Generic Medicine Tariffs Trigger 4% Slump in Indian Pharma Stocks
On July 24, major Indian pharmaceutical stocks plummeted by as much as 4% after U.S. President Donald Trump announced a proposed phased tariff plan on imported generic medicines, sparking immediate…
